Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400087374Phase 4Not yet recruiting
Phase 4, randomised trial of oliceridine in difficult airway (2 arms), sponsored by The First Affiliated Hospital of Chengdu Medical College. Primary endpoints: Hemodynamic indices, Ramsay Sedation Rating and 5 more. Planned start Jul 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400087374.